Cyclosporin a induces apoptosis in childhood acute lymphoblastic leukemia cells

Blood

Volumn 91, Issue 3, 1998, Pages 1001-1007

  Ito, Chikako ^b   Ribeiro, Raul C ^b   Behm, Frederick G ^b   Raimondi, Susana C ^b   Pui, Ching Hon ^b   Campana, Dario ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A;

ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; CELL FUNCTION; CELL SURVIVAL; CELL VIABILITY; ENZYME INHIBITION; GENE MUTATION; GENE REARRANGEMENT; HUMAN; HUMAN CELL; LEUKEMIA CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; STROMA CELL; T LYMPHOBLAST; TARGET CELL;

EID: 0032006790     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.3.1001     Document Type: Article

References (45)

1. Sigal NH, Dumont FJ: Cyclosporin A, FK-506, and rapamycin: Pharmacologic probes of lymphocyte signal transduction. Annu Rev Immunol 10:519, 1992
2. Schreiber SL, Crabtree GR: The mechanism of action of cyclosporin A and FK506. Immunol Today 13:136, 1992
3. Foa P, Maiolo AT, Baldini L, Maisto A, Spano M, Starace G, Quarto di Palo F, Polli EE: Antiproliferative activity of cyclosporin A on human T-lymphoblastic leukaemia cell line. Lancet 1:838, 1981
4. Totterman TH, Danersund A, Nilsson K, Killander A: Cyclosporin-A is selectively cytotoxic to human leukemic T cell in vitro. Blood 59:1103, 1982
5. Fidelus RK, Orosz C, Ferguson RM: The effect of cyclosporin A (CsA) on murine and human T and B cell tumor lines. Transplant Proc 15:554, 1983
6. McLachlan G, Thomson AW, Wallace HM: Growth inhibition of the MOLT-4 human T-leukemia cell line. A comparison of cyclosporin and FK506. Transplant Proc 23:2831, 1991
7. Gabor EP, Mishalani S, Lee S: Rapid response to cyclosporine therapy and sustained remission in large granular lymphocyte leukemia. Blood 87:1199, 1995
8. Manabe A, Coustan-Smith E, Behm F, Raimondi SC, Campana D: Bone marrow derived stromal cells prevent apoptotic cell death in B lineage acute lymphoblastic leukemia. Blood 79:2370, 1992
9. Campana D, Manabe A, Evans WE: Stroma-supported immunocytometric assay (SIA): A novel method for testing the sensitivity of acute lymphoblastic leukemia cells to cytotoxic drugs. Leukemia 7:482, 1993
10. Manabe A, Murti KG, Coustan-Smith E, Kumagai M, Behm FG, Raimondi SC, Campana D: Adhesion-dependent survival of normal and leukemic human B lymphoblasts on bone marrow stromal cells. Blood 83:758, 1994
11. Manabe A, Coustan-Smith E, Kumagai M, Behm FG, Raimondi SC, Pui C-H, Campana D: Interleukin-4 induces programmed cell death (apoptosis) in cases of high risk acute lymphoblastic leukemia. Blood 83:1731, 1994
12. Kumagai M, Coustan-Smith E, Murry DJ, Silvennoinen O, Murti KG, Evans WE, Malavasi F, Campana D: Ligation of CD38 suppresses human B lymphopoiesis. J Exp Med 181:1101, 1995
13. Kumagai M, Manabe A, Pui C-H, Behm FG, Raimondi SC, Hancock ML, Mahmoud H, Crist WM, Campana D: Stroma-supported culture of childhood B-lineage acute lymphoblastic leukemia cells on bone marrow stroma predicts treatment outcome. J Clin Invest 97:755, 1996
14. Ito C, Evans WE, McNinch L, Coustan-Smith E, Mahmoud H, Pui CH, Campana D: Comparative cytotoxicity of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia. J Clin Oncol 14:2370, 1996
15. Nishigaki H, Ito C, Manabe A, Kumagai M, Coustan-Smith E, Yanishevski Y, Behm FG, Raimondi SC, Pui CH, Campana D: Prevalence and growth characteristics of malignant stem cells in B-lineage acute lymphoblastic leukemia. Blood 89:3735, 1997
16. Beck WT, Mueller TJ, Tanzer LR: Altered surface membrane glycoproteins in vinca alkaloid-resistant human leukemic lymphoblasts. Cancer Res 39:2070, 1979
17. Danks MK, Yalowich JC, Beck WT: Atypical multiple drug resistance in a human leukemic cell line selected for resistance to teniposide (VM-26). Cancer Res 47:1297, 1987
18. DeLean A, Munson PJ, Rodbord D: Simultaneous analysis of families of sigmoid curves: Application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol 235:E97, 1978
19. Martin SJ, Reutelingsperger CPM, McGahon AJ, Rader JA, Van Schie RCA, LaFace DM, Green DR: Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by overexpression of Bcl-2 and AbI. J Exp Med 182:1597, 1995
20. Pui CH: Childhood leukemias. N Engl J Med 332:1618, 1995
21. Frassoni F, Bacigalupo A, Piaggio G, Podesta M, Repetto M, Marmont AM: Effect of cyclosporin A (CyA) on the in vitro growth of hemopoietic progenitors from normal marrow. Exp Hematol 13:1084, 1985
22. Raghavachar A, Frickhofen N, Arnold R, Schmeiser T, Porzsolt F, Heimpel H: Hematopoietic colony formation after allogeneic bone marrow transplantation: Enhancement by cyclosporin A and anti-γ-(immune) interferon antiserum in vitro. Exp Hematol 14:621, 1986
23. Kalechman Y, Sredni B, Capsi RR, Nussenblatt RB: Enhancing effects of cyclosporins A and G on bone marrow colony formation. Exp Hematol 18:1104, 1990
24. Hirao A, Kawano Y, Takaue Y: Effects of immunosuppressants, FK506, deoxyspergualin, and cyclosporine A on immature human hematopoiesis. Blood 81:1179, 1993
25. Baum CM, Weissman IL, Tsukamoto AS, Bucle AM, Peault B: Isolation of a candidate human hematopoietic stem-cell population. Proc Natl Acad Sci USA 89:2804, 1992
26. + cells. Leukemia 6:845, 1992
27. Darzynkiewicz Z, Juan G, Li X, Gorczyca W, Murakami T, Traganos F: Cytometry in cell necrobiology: Analysis of apoptosis and accidental cell death (necrosis). Cytometry 27:1, 1997
28. Wyllie AH, Kerr JFR, Currie AR: Cell death: The significance of apoptosis. Int Rev Cytol 68:251, 1980
29. Tomei LD, Kanter P, Wenner CE: Inhibition of radiation-induced apoptosis in vitro by tumor promoters. Biochem Biophys Res Commun 155:324, 1988
30. McConkey DJ, Hartzell P, Jondal M, Orrenius S: Inhibition of DNA fragmentation in thymocytes and isolated thymocyte nuclei by agents that stimulate protein kinase C. J Biol Chem 264:13399, 1989
31. Obeid LM, Linardic CM, Karolak LA, Hannun YA: Programmed cell death induced by ceramide. Science 259:1769, 1993
32. Cuvillier O, Pirianov G, Kleuser B, Vanek PG, Coso OA, Gutkind JS, Spiegel S: Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 381:800, 1996
33. Bose R, Verheij M, Haimovitz-Friedman A, Scotto K, Fuks Z, Kolesnick R: Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signals. Cell 82:405, 1995
34. Yano H, Nakanishi S, Kimura K, Hanai N, Saitoh Y, Fukui Y, Nonmura Y, Matsuda Y: Inhibition of histamine secretion by wortmannin through the blockade of phosphatidylinositol 3-kinase in RBL-2H3 cells. J Biol Chem 268:25846, 1993
35. Beckwith M, Fenton RG, Katona IM, Longo DL: Phosphatidylinositol-3-kinase activity is required for the anti-Ig-mediated growth inhibition of a human B-lymphoma cell line. Blood 87:2020, 1996
36. Kitanaka A, Ito C, Nishigaki H, Campana D: CD38-mediated growth suppression of B cell progenitors requires activation of phosphatidylinositol 3-kinase and involves its association with the protein product of the c-cbl proto-oncogene. Blood 88:590, 1996
37. Eischen CM, Dick CJ, Leibson PJ: Tyrosine kinase activation provides an early and requisite signal for Fas-induced apoptosis. J Immunol 153:1947, 1994
38. Wicker LS, Boltz RC, Matt V, Nichols EA, Peterson LB, Sigal NH: Suppression of B cell activation by cyclosporin A, FK506 and rapamycin. Eur J Immunol 20:2277, 1990
39. Gottschalk AR, Boise LH, Thompson CB, Quintans J: Identification of immunosuppressant-induced apoptosis in a murine B-cell line and its prevention by bcl-x but not bcl-2. Proc Natl Acad Sci USA 91:7350, 1994
40. Preti A, Kantarjian HM: Management of adult acute lymphocytic leukemia: Present issues and key challenges. J Clin Oncol 12:1312, 1994
41. Slater LM, Sweet P, Stupecky M, Gupta S: Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitro. J Clin Invest 77:1405, 1986
42. Ross DD, Woolen PJ, Sridhara R, Ordonez JV, Lee EJ, Schiffer CA: Enhancement of daunorubicin accumulation, retention, and cytotoxicity by verapamil or cyclosporin A in blast cells from patients with previously untreated acute myeloid leukemia. Blood 82:1288, 1993
43. Slater LM, Wetzel M, Cho J, Sweet P: Development of cyclosporin A mediated immunity in L1210 leukaemia. Br J Cancer 64:1098, 1991
44. Yahanda AM, Adler KM, Fisher GA, Brophy NA, Halsey J, Hardy RI, Gosland MP, Lum BL, Sikic BI: Phase I trial of etoposide with cyclosporine as a modulator of multidrug resistance. J Clin Oncol 10:1624, 1992
45. List AF, Spier C, Greer J, Wolff S, Hutter J, Dorr R, Salmon S, Futscher B, Baier M, Dalton W: Phase I/II trial of cyclosporine as a chemotherapy-resistance modifier in acute leukemia. J Clin Oncol 11:1652, 1993